The nomination committee’s proposal of board of directors in ADDvise Group AB (publ) - Regulatory information

06-03-2020   Regulatory press release

The nomination committee of ADDvise Group AB (publ) has decided to propose the reelection of the current board members Rikard Akhtarzand and Fredrik Celsing as members of the board of directors at the annual general Meeting (AGM) 2020. In addition, the nomination committee proposes election of Staffan Torstensson and Erland Pontusson. Furthermore, it is proposed that Staffan Torstensson is elected chairman of the board of directors. The current chairman of the board of directors, Meg Tivéus, has declined re-election.

Staffan Torstensson has a Master of Science in Business Administration, Jönköping International Business School and is operating as partner at Evli Bank within corporate finance. Staffan Torstensson is currently board member in Tuida Holding AB.

Erland Pontusson has a Master of Science in Business and Economics, Stockholm University, performed an AMP, Stockholm Institute of International Business and commenced as COO in ADDvise Group in 2016. Erland has had numerous management positions within medical technology and IT, such as Philips, Fujitsu, VWR International and LIC Care.

A presentation of the current members of the board of directors is available on ADDvise Group’s website.

The nomination committee's complete proposals for resolutions at the annual general meeting 2020 will be published in connection with the notice of the annual general meeting 2020.

The nomination committee for the annual general meeting 2020 in ADDvise Group consists of Per-Anders Tammerlöv (chairman of the nomination committee) appointed by Rikard Akhtarzand, shareholder through direct and indirect ownership, Per Åhlgren, shareholder through indirect ownership, Magnus Vahlquist, shareholder through direct and indirect ownership and Meg Tivéus, chairman of ADDvise Group AB. The nomination committee jointly represents approximately 45 per cent of the votes in the company.  

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 6 March 2020 at 16:30 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50,, is the Company's Certified Adviser. Additional information is available at


Latest press releases

ADDvise announces preliminary result for 2022 which is stronger than expected


The preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…

ADDvise receives order worth USD 3.5 million


ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…

ADDvise receives order worth USD 1.8 million


ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…